PTG-200 - Protagonist Therapeutics, J&J
PTG-200: Data from P2 PRISM trial (NCT04102111) for Crohn's disease in H1 2021 (Protagonist Therapeutics) - Feb 6, 2020 - Corporate Presentation 
P2 data
http://investors.protagonist-inc.com/static-files/606743d7-ec47-46d5-985e-df29839f9dbc
 
Feb 6, 2020
 
 
ee74d811-3ee2-45f6-8f10-0cab0c5b0ea1.jpg